McClellan Outlines Vision For Device User Fees, Third-Party Inspections
This article was originally published in The Gray Sheet
Executive Summary
Incoming FDA commissioner Mark McClellan, MD/PhD, is pledging to hold the agency to premarket review performance goals mandated under the "Medical Device User Fee and Modernization Act" if the bill becomes law